Health & Healthcare

Gilead Sciences Inc. (Nasdaq: GILD) announced its largest commitment to health equity for Australian and Canadian Indigenous communities.

Gilead provided a grant for the innovative partnership as part of its overall efforts to advance health equity and reduce stigma and disparities in communities of greatest need.

Gilead has been at the forefront of helping transform the treatment and prevention of HIV for decades, and it is also focused on helping speed the development and accessibility of new medications for children.

Earlier this month, the National League of Cities (NLC) and the International WELL Building Institute (IWBI) teamed up to host an important and timely webcast titled, “Elevating Health across Sustainability Initiatives - Systematic Approach to Creating a Resilient Future.”

Viatris Inc. and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application approved by the U.S. Food and Drug Administration (FDA).

Competition from generic and biosimilar medicines is a fundamental component of health systems’ ability to expand and sustain patient access to medicines. Generic medicines generally represent between 60-80% of all medicine sales by volume in key markets globally,

The Mental Health Action Plan signals the IOC’s intent to integrate expert-led support for athletes’ well-being across multiple IOC programmes, working on complementary topics such as gender equality and safeguarding, with the support of Olympic Solidarity.

Illumina and Pillar Biosciences Inc., the pioneers of Decision Medicine™, announced a strategic partnership to make Pillar's suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products.

Comprehensive genomic profiling (CGP) assesses hundreds of tumor genes to find actionable mutations and is becoming the standard of care for many cancers. However, oncologists often opt for single-gene tests (SGT) before pursuing CGP.

Nothing about Budi Hermawan’s experience with tuberculosis (TB) has been easy. In 2003, he had a cough. He didn’t think much of it, but as his symptoms worsened, he visited a doctor near his home in Bogor, Indonesia.